Literature DB >> 30185102

ST3GAL5-Related Disorders: A Deficiency in Ganglioside Metabolism and a Genetic Cause of Intellectual Disability and Choreoathetosis.

Eliza Gordon-Lipkin1,2,3, Julie S Cohen4, Siddharth Srivastava5, Bruno P Soares6, Eric Levey1,3, Ali Fatemi1,2,3,4.   

Abstract

GM3 synthase deficiency is due to biallelic pathogenic variants in ST3GAL5, which encodes a sialyltransferase that synthesizes ganglioside GM3. Key features of this rare autosomal recessive condition include profound intellectual disability, failure to thrive and infantile onset epilepsy. We expand the phenotypic spectrum with 3 siblings who were found by whole exome sequencing to have a homozygous pathogenic variant in ST3GAL5, and we compare these cases to those previously described in the literature. The siblings had normal birth history, subsequent developmental stagnation, profound intellectual disability, choreoathetosis, failure to thrive, and visual and hearing impairment. Ichthyosis and self-injurious behavior are newly described in our patients and may influence clinical management. We conclude that GM3 synthase deficiency is a neurodevelopmental disorder with consistent features of profound intellectual disability, choreoathetosis, and deafness. Other phenotypic features have variable expressivity, including failure to thrive, epilepsy, regression, vision impairment, and skin findings. Our analysis demonstrates a broader phenotypic range of this potentially under-recognized disorder.

Entities:  

Keywords:  GM3 synthase; ST3GAL5; cerebral palsy; gangliosides; intellectual disability

Mesh:

Substances:

Year:  2018        PMID: 30185102      PMCID: PMC6188822          DOI: 10.1177/0883073818791099

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  11 in total

1.  A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation.

Authors:  Luigi Boccuto; Kazuhiro Aoki; Heather Flanagan-Steet; Chin-Fu Chen; Xiang Fan; Frank Bartel; Marharyta Petukh; Ayla Pittman; Robert Saul; Alka Chaubey; Emil Alexov; Michael Tiemeyer; Richard Steet; Charles E Schwartz
Journal:  Hum Mol Genet       Date:  2013-09-10       Impact factor: 6.150

2.  Cutaneous dyspigmentation in patients with ganglioside GM3 synthase deficiency.

Authors:  Heng Wang; Alicia Bright; Baozhong Xin; J R Bockoven; Amy S Paller
Journal:  Am J Med Genet A       Date:  2013-02-22       Impact factor: 2.802

3.  GM3 synthase deficiency due to ST3GAL5 variants in two Korean female siblings: Masquerading as Rett syndrome-like phenotype.

Authors:  Jin Sook Lee; Yongjin Yoo; Byung Chan Lim; Ki Joong Kim; Junghan Song; Murim Choi; Jong-Hee Chae
Journal:  Am J Med Genet A       Date:  2016-05-27       Impact factor: 2.802

Review 4.  Self-injurious behavior in neurodevelopmental disorders: relevance of nociceptive and immune mechanisms.

Authors:  Frank J Symons
Journal:  Neurosci Biobehav Rev       Date:  2011-01-13       Impact factor: 8.989

5.  Etiology of vision loss in ganglioside GM3 synthase deficiency.

Authors:  Fahhad Farukhi; Claudia Dakkouri; Heng Wang; Max Wiztnitzer; Elias I Traboulsi
Journal:  Ophthalmic Genet       Date:  2006-09       Impact factor: 1.803

6.  Refractory epilepsy and mitochondrial dysfunction due to GM3 synthase deficiency.

Authors:  Konstantina Fragaki; Samira Ait-El-Mkadem; Annabelle Chaussenot; Catherine Gire; Raymond Mengual; Laurent Bonesso; Marie Bénéteau; Jean-Ehrland Ricci; Valérie Desquiret-Dumas; Vincent Procaccio; Agnès Rötig; Véronique Paquis-Flucklinger
Journal:  Eur J Hum Genet       Date:  2012-09-19       Impact factor: 4.246

7.  Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase.

Authors:  Michael A Simpson; Harold Cross; Christos Proukakis; David A Priestman; David C A Neville; Gabriele Reinkensmeier; Heng Wang; Max Wiznitzer; Kay Gurtz; Argyro Verganelaki; Anna Pryde; Michael A Patton; Raymond A Dwek; Terry D Butters; Frances M Platt; Andrew H Crosby
Journal:  Nat Genet       Date:  2004-10-24       Impact factor: 38.330

Review 8.  The role of glycosphingolipid metabolism in the developing brain.

Authors:  Robert K Yu; Yoshihiko Nakatani; Makoto Yanagisawa
Journal:  J Lipid Res       Date:  2008-10-09       Impact factor: 5.922

9.  Early growth and development impairments in patients with ganglioside GM3 synthase deficiency.

Authors:  H Wang; A Wang; D Wang; A Bright; V Sency; A Zhou; B Xin
Journal:  Clin Genet       Date:  2016-01-20       Impact factor: 4.438

10.  Clinical application of whole-exome sequencing across clinical indications.

Authors:  Kyle Retterer; Jane Juusola; Megan T Cho; Patrik Vitazka; Francisca Millan; Federica Gibellini; Annette Vertino-Bell; Nizar Smaoui; Julie Neidich; Kristin G Monaghan; Dianalee McKnight; Renkui Bai; Sharon Suchy; Bethany Friedman; Jackie Tahiliani; Daniel Pineda-Alvarez; Gabriele Richard; Tracy Brandt; Eden Haverfield; Wendy K Chung; Sherri Bale
Journal:  Genet Med       Date:  2015-12-03       Impact factor: 8.822

View more
  4 in total

1.  Dystonia Due to GM3 Synthase Deficiency.

Authors:  Alexander S Wang; Camilla Kilbane
Journal:  Mov Disord Clin Pract       Date:  2022-01-05

Review 2.  Skin Conditions and Movement Disorders: Hiding in Plain Sight.

Authors:  Kristina Kulcsarova; Janette Baloghova; Jan Necpal; Matej Skorvanek
Journal:  Mov Disord Clin Pract       Date:  2022-03-24

Review 3.  Ganglioside GM3 Synthase Deficiency in Mouse Models and Human Patients.

Authors:  Kei-Ichiro Inamori; Jin-Ichi Inokuchi
Journal:  Int J Mol Sci       Date:  2022-05-11       Impact factor: 6.208

Review 4.  A Proposed Diagnostic Algorithm for Inborn Errors of Metabolism Presenting With Movements Disorders.

Authors:  Juan Darío Ortigoza-Escobar
Journal:  Front Neurol       Date:  2020-11-13       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.